Munafa Stock Market Course + Intraday & FNO calls 
Protagonist Therapeutics (PTGX) Technical (Analysis) Reports Protagonist Therapeutics ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Protagonist Therapeutics (PTGX)
Technical Analysis Report for USA stock PTGX Protagonist Therapeutics. Dated: 09 Feb 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in USA stock exchange
If you are looking for Tomorrow's Movement Predictions for USA stock PTGX Protagonist Therapeutics then click here. or read Experts views on Protagonist Therapeutics or Forecast & share price targets of Protagonist Therapeutics
Protagonist Therapeutics Opened at 83.47 and Closed at: 83.32, which is -1.4% of previous session's close. It moved within a range of 82.21 and 83.90
The session was a Bearish session with an average volume of 322000, which is -152.42% of previous session's volumes.
- The stock has fallen, and its mid term trend is also negative and in a downtrend.
- Even though the stock has fallen, but its long term trend is positive and in an uptrend.
A Dead cross was found 3 days back on short term averages
A Golden cross was found 6 days back on short term averages
A Dead cross was found 8 days back on short term averages
A Golden cross was found 9 days back on short term averages
Support for tomorrow is 81.92 and resistance for tomorrow is 83.61
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 82.39, 81.45 resistance for tomorrow's hourly charts is 84.08, 84.83
10 Day SMA for Protagonist Therapeutics (PTGX) is 82.68 and stock is trading above these levels. This is a good sign for its short term trend
20 Day SMA for Protagonist Therapeutics (PTGX) is 82.89 and the stock is trading above these levels. This is a good sign for its mid term trend
50 Day SMA for Protagonist Therapeutics (PTGX) is 85.79 and the stock is trading below these levels. This is not a good sign for its mid to long term trend
100 Day SMA is 80.37 and the stock is trading above these levels. This is a good sign for its long term trend
200 Day SMA Protagonist Therapeutics is 66.43 and stock is trading above these levels. This is a good sign for its long term trend
20 DMA of Protagonist Therapeutics is at 82.89 and 200 DMA is at 66.43, while 50 DMA and 100 DMA are at 85.79 and 80.37 respectively
Protagonist Therapeutics (PTGX) moving average of 20 SMA is at 82.89 and 20 EMA is at 83.3
| Date | Closing Price | 20 SMA | 20 EMA |
| 09 Mon Feb | 83.32 | 82.89 | 83.3 |
| 06 Fri Feb | 84.49 | 82.74 | 83.3 |
| 05 Thu Feb | 80.67 | 82.52 | 83.17 |
| 04 Wed Feb | 83.30 | 82.61 | 83.43 |
| 03 Tue Feb | 85.59 | 82.56 | 83.44 |
| 02 Mon Feb | 83.05 | 82.49 | 83.21 |
Protagonist Therapeutics (PTGX) moving average of 50 SMA is at 85.79 and 50 EMA is at 83.23
| Date | Closing Price | 50 SMA | 50 EMA |
| 09 Mon Feb | 83.32 | 85.79 | 83.23 |
| 06 Fri Feb | 84.49 | 85.92 | 83.23 |
| 05 Thu Feb | 80.67 | 85.98 | 83.18 |
| 04 Wed Feb | 83.30 | 86.07 | 83.28 |
| 03 Tue Feb | 85.59 | 86.09 | 83.28 |
| 02 Mon Feb | 83.05 | 86.08 | 83.19 |
Protagonist Therapeutics (PTGX) moving average of 100 SMA is at 80.37 and 100 EMA is at 78.88
| Date | Closing Price | 100 SMA | 100 EMA |
| 09 Mon Feb | 83.32 | 80.37 | 78.88 |
| 06 Fri Feb | 84.49 | 80.13 | 78.79 |
| 05 Thu Feb | 80.67 | 79.86 | 78.67 |
| 04 Wed Feb | 83.30 | 79.65 | 78.63 |
| 03 Tue Feb | 85.59 | 79.41 | 78.54 |
| 02 Mon Feb | 83.05 | 79.13 | 78.4 |
Protagonist Therapeutics (PTGX) moving average of 200 SMA is at 66.43 and 200 EMA is at 70.04
| Date | Closing Price | 200 SMA | 200 EMA |
| 09 Mon Feb | 83.32 | 66.43 | 70.04 |
| 06 Fri Feb | 84.49 | 66.24 | 69.91 |
| 05 Thu Feb | 80.67 | 66.05 | 69.76 |
| 04 Wed Feb | 83.30 | 65.87 | 69.65 |
| 03 Tue Feb | 85.59 | 65.69 | 69.51 |
| 02 Mon Feb | 83.05 | 65.49 | 69.35 |
Protagonist Therapeutics has performed better than Edwards Lifesciences in short term. Holding Protagonist Therapeutics could be a better choice for now!
Protagonist Therapeutics has performed better than Conmed Corporation in short term. Holding Protagonist Therapeutics could be a better choice for now!
Cardinal Health has performed better than Protagonist Therapeutics in short term. You could have earned much better returns by investing in Cardinal Health, about 7.65% more returns!
Protagonist Therapeutics has performed better than Verastem Inc in short term. Holding Protagonist Therapeutics could be a better choice for now!
Protagonist Therapeutics has performed better than Verrica Pharmaceuticals in short term. Holding Protagonist Therapeutics could be a better choice for now!
Protagonist Therapeutics has performed better than Replimune Group in short term. Holding Protagonist Therapeutics could be a better choice for now!
Protagonist Therapeutics has performed better than Rocket Pharmaceuticals in short term. Holding Protagonist Therapeutics could be a better choice for now!
Protagonist Therapeutics has performed better than Ocular Therapeutix in short term. Holding Protagonist Therapeutics could be a better choice for now!
Neurocrine Biosciences has performed better than Protagonist Therapeutics in short term. You could have earned much better returns by investing in Neurocrine Biosciences, about 1.37% more returns!
Protagonist Therapeutics has performed better than Insmed Inc in short term. Holding Protagonist Therapeutics could be a better choice for now!
Protagonist Therapeutics has performed better than Integra Lifesciences in short term. Holding Protagonist Therapeutics could be a better choice for now!
Fortress Biotech has performed better than Protagonist Therapeutics in short term. You could have earned much better returns by investing in Fortress Biotech, about 16.78% more returns!
Protagonist Therapeutics has performed better than Eyegate Pharmaceuticals in short term. Holding Protagonist Therapeutics could be a better choice for now!
Protagonist Therapeutics has performed better than Cytokinetics Incorporated in short term. Holding Protagonist Therapeutics could be a better choice for now!
Protagonist Therapeutics has performed better than Collegium Pharmaceutical in short term. Holding Protagonist Therapeutics could be a better choice for now!
Protagonist Therapeutics has performed better than Biomerica Inc in short term. Holding Protagonist Therapeutics could be a better choice for now!
Biogen Inc has performed better than Protagonist Therapeutics in short term. You could have earned much better returns by investing in Biogen Inc, about 0.58% more returns!
Protagonist Therapeutics has performed better than Apellis Pharmaceuticals in short term. Holding Protagonist Therapeutics could be a better choice for now!
Protagonist Therapeutics has performed better than Agenus Inc in short term. Holding Protagonist Therapeutics could be a better choice for now!
Protagonist Therapeutics Technical analysis of indicators
Price action analysis of Protagonist Therapeutics (PTGX) based on a short term time period is neutral. A longer time frame might give a better analysis.
ADX buy sell signal for Protagonist Therapeutics stock for short term is SELL. Signal strength is Strong and stock is gaining momentum.
MACD generated a BUY signal for Protagonist Therapeutics in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Protagonist Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting stronger in this stock.
Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Protagonist Therapeutics in short term but SELL signal is weak.
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Protagonist Therapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 82.66 and Protagonist Therapeutics PTGX stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Protagonist Therapeutics PTGX stock. Volume based technical analysis of Protagonist Therapeutics PTGX stock is negative.
Protagonist Therapeutics Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for USA stock PTGX Protagonist Therapeutics These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And PTGX Experts View which covers a lot of information including buying and selling signals
PTGX future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Protagonist Therapeutics or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Protagonist Therapeutics (PTGX) Technical (Analysis) Reports Protagonist Therapeutics ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Hindi Basics How To Trade In FnO Futures Options Stock Market
Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You
- USA Screeners
- USA Daily Screener
- USA Weekly Screener
- USA Monthly Screener
- Support & Resistance
- USA Shares Near Support
- USA Shares Near Resistance
